Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients  Yoshitomo Okumura, MD, Fumihiro Tanaka, MD, PhD, Kazue Yoneda, Masaki.

Slides:



Advertisements
Similar presentations
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Advertisements

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease  Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer 
Long-Term Survival of Patients With pN2 Lung Cancer According to the Pattern of Lymphatic Spread  Antoine Legras, MD, Pierre Mordant, MD, PhD, Alex Arame,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
A Scimitar Syndrome Variant: Anomalous Systemic Arterial Supply to the Right Lung With Normal Pulmonary Venous Return  Luis Gorospe, MD, Amparo Esteban-Peris,
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer
Kunal Mehta, BSE, Erika Moravcikova, PhD, David McFall, AB, James D
Invasive Mediastinal Staging Guideline Concordance
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches  Matthew.
A Systematic Review of Pulmonary Embolism in Patients With Lung Cancer
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.
Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases
Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery 
Clinical Value of Serum Cytokeratin 19 Fragment and Sialyl-Lewis X in Non-Small Cell Lung Cancer  Shinjiro Mizuguchi, MD, PhD, Noritoshi Nishiyama, MD,
Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival  Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,
Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy  Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Preliminary Investigation of the Clinical Significance of Detecting Circulating Tumor Cells Enriched from Lung Cancer Patients  Chi Wu, MD, Huaijie Hao,
Philip W. Smith, MD, Hongkun Wang, PhD, Leo M. Gazoni, MD, K
Prox-1: A Specific and Sensitive Marker for Lymphatic Endothelium in Normal and Diseased Human Tissues  Eumenia Costa da Cunha Castro, MD, PhD, Csaba.
Lung Cancer Surgery in Patients With Liver Cirrhosis
Who Do You Say You Are? The Annals of Thoracic Surgery
Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer  Anthony W.
Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma  Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.
Use of Amiodarone After Major Lung Resection
Relation Between Thin-Section Computed Tomography and Clinical Findings of Mucinous Adenocarcinoma  Hajime Watanabe, MD, Haruhiro Saito, MD, Tomoyuki.
Abel Gómez-Caro, MD, Pedro Arguis, MD  The Annals of Thoracic Surgery 
Complete Resection of Oligorecurrence of Stage I Lung Adenocarcinoma 19 Years After Operation  Dai Sonoda, MD, Masashi Mikubo, MD, Kazu Shiomi, MD, PhD,
Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer  Raymond U.
Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma  Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.
Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer  Lisa M. Brown, MD, Brian.
Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD 
Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer  Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.
Surgical Therapy for Bilateral Multiple Primary Lung Cancer
Pulmonary Resection for Lung Cancer in Octogenarians
Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis  Alessandro Marra, MD, PhD, Ludger Hillejan, MD,
Luca Roncati, MD, PhD, Antonio Manenti, MD, PhD 
Editorial Board, January 2010
Severe Two-Vessel Ostial Stenosis of the Main Coronary Arteries in a Patient With Transposition of the Great Arteries After an Arterial Switch Operation 
Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery  Fausto Biancari, MD, PhD, Eeva-Maija.
Extensive Invasion of the Left Atrium by Lung Cancer
Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor
Deterioration of a Tricuspid Bioprosthesis Due to Adhesion of the Native Valve  Herbert Gutermann, MD, Willem Flameng, MD, PhD, Paul Herijgers, MD, PhD 
The Annals of Thoracic Surgery
Capillary Hemangioma in a Rib Presenting as Large Pleural Effusion
Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size  Elizabeth David, MD, Peter F. Thall, PhD,
Contemporary Outcomes of Surgical Repair of Total Anomalous Pulmonary Venous Connection in Patients With Heterotaxy Syndrome  Muhammad S. Khan, MD, Roosevelt.
Philip A. Linden, MD, Jon O. Wee, MD, Michael T
Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer  Pamela Samson, MD,
Daniel A. Anaya, MD, Mujun Yu, MD, Riyad Karmy-Jones, MD 
Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study  Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,
The Annals of Thoracic Surgery
Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection  Daniel L. Miller, MD, Gerald A. Helms, MD,
Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D
Neal S Goldstein, MD  The Annals of Thoracic Surgery 
Primary Yolk Sac Tumor of the Lung
Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease  Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,
Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis  Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.
Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study  Robert J. Cerfolio, MD, Ayesha.
Mark I. Block, MD  The Annals of Thoracic Surgery 
Lobectomy Versus Limited Resection in T1N0 Lung Cancer
The Impact of New Technology on Cardiothoracic Surgical Practice
Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD 
Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis  Alfonso Fiorelli, MD, PhD, Marina Accardo, MD, Emanuele Carelli,
Presentation transcript:

Circulating Tumor Cells in Pulmonary Venous Blood of Primary Lung Cancer Patients  Yoshitomo Okumura, MD, Fumihiro Tanaka, MD, PhD, Kazue Yoneda, Masaki Hashimoto, MD, Teruhisa Takuwa, MD, Nobuyuki Kondo, MD, Seiki Hasegawa, MD, PhD  The Annals of Thoracic Surgery  Volume 87, Issue 6, Pages 1669-1675 (June 2009) DOI: 10.1016/j.athoracsur.2009.03.073 Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Circulating tumor cells (CTCs) displayed by the CellSearch system. Cells captured with an anti–epithelial cell adhesion molecule (EpCAM) antibody were stained with (4′,6-diamidino-2-phenylindole (DAPI), an anti-cytokeratin antibody conjugated with phycoerythrin (CK-PE), and an anti-CD45 antibody conjugated with allophycocyanin (CD45-APC). Cells with round to oval morphology, a visible DAPI-positive nucleus, positive CK-PE staining in the cytoplasm, and negative staining for CD45-APC were judged as CTCs (cells 1, 2, and 3). Contaminated leukocytes were identified as DAPI+/CK−/CD45+ cells (cell 5). The CD45-positive cells were not judged as CTCs even when cells were positively stained for DAPI and CK-PE (cell 4). The Annals of Thoracic Surgery 2009 87, 1669-1675DOI: (10.1016/j.athoracsur.2009.03.073) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Distribution of circulating tumor cells (CTCs) in pulmonary venous blood (pvCTC count) in correlation with CTCs in peripheral blood (periCTC count). The number of CTCs per 7.5 mL of each blood sample was represented as the CTC count, and pvCTC count was shown in log10 scale. The Annals of Thoracic Surgery 2009 87, 1669-1675DOI: (10.1016/j.athoracsur.2009.03.073) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Distribution of circulating tumor cells (CTCs) in pulmonary venous blood (pvCTC) according to (A) histologic type, (B) pathologic (p) stage, (C) primary tumor site, (D) microscopic vessel invasion of primary tumor, and (E) microscopic lymphatic invasion of primary tumor. The number of CTCs per 7.5 mL of each pulmonary blood sample was represented as the pvCTC count, and pvCTC count was shown in log10 scale. The Annals of Thoracic Surgery 2009 87, 1669-1675DOI: (10.1016/j.athoracsur.2009.03.073) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions